[1]吕灵海.血液灌流串联血液透析治疗对终末期糖尿病肾病患者微炎症及营养状态的影响[J].医学信息,2022,35(19):35-37.[doi:10.3969/j.issn.1006-1959.2022.19.009]
　LYU Ling-hai.Effect of Hemoperfusion Combined with Hemodialysis on Microinflammation and Nutritional Status in Patients with End-stage Diabetic Nephropathy[J].Journal of Medical Information,2022,35(19):35-37.[doi:10.3969/j.issn.1006-1959.2022.19.009]
点击复制

血液灌流串联血液透析治疗对终末期糖尿病肾病患者微炎症及营养状态的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年19期
页码:
35-37
栏目:
论著
出版日期:
2022-10-01

文章信息/Info

Title:
Effect of Hemoperfusion Combined with Hemodialysis on Microinflammation and Nutritional Status in Patients with End-stage Diabetic Nephropathy
文章编号:
1006-1959（2022）19-0035-03
作者:
吕灵海
（上饶市广信区人民医院肾内科，江西 上饶 334100）
Author(s):
LYU Ling-hai
(Department of Nephrology,Guangxin District People’s Hospital,Shangrao 334100,Jiangxi,China)
关键词:
终末期糖尿病肾病; 血流灌注; 血液透析; 炎症; 营养状态
Keywords:
End-stage diabetic nephropathy; Blood perfusion; Hemodialysis; Inflammation; Nutritional status
分类号:
R692.5；R587.2
DOI:
10.3969/j.issn.1006-1959.2022.19.009
文献标志码:
A
摘要:
目的 探讨血液灌流（HP）串联血液透析（HD）治疗对终末期糖尿病肾病（ESDN）患者微炎症及营养状态的影响。方法 选取2018年5月-2021年6月我院收治的ESDN患者60例，随机分为HD组和串联组，每组30例。HD组给予HD治疗，串联组给予HP串联HD治疗。以12周为治疗周期，比较两组治疗前后微炎症、营养状况、BMI指数及生活质量改善情况。结果 两组微炎症指标、营养指标优于治疗前，且串联组优于HD组，差异有统计学意义（P＜0.05）；两组BMI、生活质量评分高于治疗前，且串联组高于HD组，差异有统计学意义（P＜0.05）。结论 ESDN患者行HP串联HD治疗，能够促进机体微炎症状况减退，改善营养状况，提高患者生活质量，是较理想的治疗方案。
Abstract:
Objective To investigate the effect of hemoperfusion (HP) combined with hemodialysis (HD) on microinflammation and nutritional status in patients with end-stage diabetic nephropathy (ESDN).Methods Sixty patients with ESDN admitted to our hospital from May 2018 to June 2021 were randomly divided into HD group and series group, with 30 cases in each group. HD group was given HD treatment, and series group was given HP series HD treatment. The improvement of microinflammation, nutritional status, BMI index and quality of life before and after treatment were compared between the two groups.Results The micro-inflammatory indexes and nutritional indexes of the two groups were better than those before treatment, and the series group was better than the HD group, the differences were statistically significant (P<0.05). The BMI and quality of life scores of the two groups were higher than those before treatment, and the series group was higher than the HD group, the differences were statistically significant (P<0.05).Conclusion HP combined with HD therapy in ESDN patients can promote the decrease of microinflammation, improve nutritional status, and improve the quality of life of patients, which is an ideal treatment plan.

参考文献/References:

[1]何传梅,刘锦秀,李慧,等.高压氧辅助血液透析联合灌流治疗对终末期糖尿病肾病患者肾功能及免疫炎性因子的影响[J].中华航海医学与高气压医学杂志,2021,28(4):460-463.[2]王祺.低分子肝素在终末期肾病规律血液透析患者行血液灌流治疗中的安全性及对凝血指标的影响[J].山西医药杂志,2021,50(10):1696-1698.[3]廖锋群.血液灌流联合透析对终末期糖尿病肾病患者胰岛素抵抗与营养状态的影响[J].医药论坛杂志,2020,41(9):77-80.[4]孙燕,曹丽,董倩兰,等.血液透析、灌流对糖尿病肾病患者血清TNF-α、CRP、IL-6水平的影响[J].现代生物医学进展,2020,20(12):2325-2328.[5]程建萍,陈玉平,黄力,等.血液透析联合血液灌流对终末期糖尿病肾病患者的预后研究[J].临床肾脏病杂志,2018,18(4):234-239.[6]韦振忠,宋雪霞,廖红霞,等.血液透析加血液灌流对终末期糖尿病肾病患者骨密度以及anti-ox-LDL-Ab水平的影响[J].疑难病杂志,2018,17(9):900-904.[7]王大鹏,高萍.血液灌流联合序贯透析对终末期糖尿病肾病患者胰岛素抵抗及微炎症状态的影响[J].中国医学前沿杂志(电子版),2018,10(1):87-90.[8]沈阳,秦明明,张洪旭.终末期肾病维持性血液透析患者的RDW、NLR水平变化及其预后分析[J].中国医药导报,2021,18(3):71-74.[9]李杨,李瑞.终末期肾病患者维持性血液透析前后认知功能状况及危险因素研究[J].贵州医药,2021,45(9):1398-1399.[10]高世洪,刘强,孟红茹.维持性血液透析患者血清钠水平与营养状态的相关性研究[J].安徽医学,2018,39(6):747-749.[11]李玉.高通量血液透析治疗糖尿病肾病临床疗效分析[J].中国药物与临床,2020,20(16):2765-2767.[12]周建华,何爱娣,周晟.健脾固肾解毒汤治疗早期糖尿病肾病的临床观察[J].中国中医药科技,2019,26(3):405-407.[13]韩辉,林书典,陈道军,等.血清微小核糖核酸-133b水平与老年糖尿病肾病患者肾脏损伤及预后的相关性[J].中华老年多器官疾病杂志,2018,17(6):420-424.[14]秦盼盼,陈朝娟.血液透析联合血液灌流对糖尿病终末期肾病患者氧化应激和胰岛功能的影响[J].河北医学,2021,27(9):1531-1535.[15]王力.糖尿病肾病患者微炎症状态与营养不良的相关性研究[J].内科急危重症杂志,2018,24(3):223-225,258.

相似文献/References:

[1]盛海龙,方长太,查佳安.超声造影对重症急性胰腺炎并发早期急性肾损的诊断价值[J].医学信息,2022,35(09):171.[doi:10.3969/j.issn.1006-1959.2022.09.044]
　SHENG Hai-long,FANG Chang-tai,ZHA Jia-an.Diagnostic Value of Contrast-enhanced Ultrasonography in Severe Acute Pancreatitis Complicated with Early Acute Kidney Injury[J].Journal of Medical Information,2022,35(19):171.[doi:10.3969/j.issn.1006-1959.2022.09.044]

更新日期/Last Update: 1900-01-01